SMYD2 and cancer: The findings that SMYD2 and SMYD3 targeted CRISPR-Cas9 knockout are well tolerated in every cell line tested and inhibitors of SMYD2 and SMYD3 have almost no detectable effects on cell proliferation, we conclude that neither the activity nor expression of these enzymes is required for in vitro cancer cell proliferation.